+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
From
From
Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Epithelial Sodium Channel (ENaC) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
ARDS - Pipeline Insight, 2025 - Product Thumbnail Image

ARDS - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Bronchodilator Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Bronchodilator Drug Market - Forecasts from 2025 to 2030

  • Report
  • June 2025
  • 147 Pages
  • Global
From
From
Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029

  • Report
  • July 2025
  • 229 Pages
  • Global
From
Sarcoidosis Therapeutics Market 2025-2029 - Product Thumbnail Image

Sarcoidosis Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 216 Pages
  • Global
From
Upper Respiratory Tract Infection Treatment Market 2025-2029 - Product Thumbnail Image

Upper Respiratory Tract Infection Treatment Market 2025-2029

  • Report
  • March 2025
  • 222 Pages
  • Global
From
Acute Respiratory Distress Syndrome Treatment Market 2025-2029 - Product Thumbnail Image

Acute Respiratory Distress Syndrome Treatment Market 2025-2029

  • Report
  • January 2025
  • 193 Pages
  • Global
From
Montelukast Sodium Market 2024-2028 - Product Thumbnail Image

Montelukast Sodium Market 2024-2028

  • Report
  • October 2024
  • 140 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more